Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 37

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 37
---
 of shares
available under the 2022 Plan, Ms. Landon was granted a five-year option to purchase a total of 4,167 shares of our common stock with
a per share exercise price to be determined by the Board on the date of grant. The options had a cashless exercise price and vest annually
over five years, with the first vesting date being December 31, 3024. On September 26, 2024, after the receipt of stockholder approval
to increase the number of shares available under the 2022 Plan, the Board approved the grant of the options to Ms. Landon at a per share
exercise price of $6.85.

<div align='center'>OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2024</div>

| Option                                                                  
 Awards                                                                  
 Name                                                                    |     | Number                                                        
 of securities underlying unexercised options, exercisable (#) |       |     | Number                                                         
 of securities underlying unexercised options unexercisable (#) |   |     | Equity                                                                              
 incentive plan awards: Number of securities underlying unexercised unearned options 
 (#)                                                                                 |       |     | Option         
 exercise price 
 ($)            |       |     | Stock              
 Awards             
 Option             
 expiration         
 date               |     | Number                                               
 of shares or units of stock that have not vested (#) |   |     | Market                                                     
 value of shares or units of stock that have not vested ($) |   |
|:------------------------------------------------------------------------|:----|:--------------------------------------------------------------|------:|:----|:---------------------------------------------------------------|:--|:----|:------------------------------------------------------------------------------------|------:|:----|:---------------|------:|:----|:-------------------|:----|:-----------------------------------------------------|:--|:----|:-----------------------------------------------------------|:--|
| Geoffrey                                                                
 Dow,                                                                    
 President and Chief Executive Officer (Principal Executive Officer)(1)  |     |                                                               | 1,000 |     |                                                                | - |     |                                                                                     | 4,000 |     | $              | 60.00 |     | July               
 16, 2034           |     |                                                      | - |     | $                                                          | - |
| Tyrone                                                                  
 Miller,                                                                 
 Chief Financial Officer (Principal Financial and Accounting Officer)(2) |     |                                                               |   800 |     |                                                                | - |     |                                                                                     | 3,200 |